Skip to main content
. 2025 Oct 4;32(10):558. doi: 10.3390/curroncol32100558
CI confidence interval
CTLA-4 cytotoxic T-lymphocyte antigen 4
FT3 free triiodothyronine
FT4 free thyroxine
ICI immune checkpoint inhibitor
IQR interquartile range
irAE immune-related adverse events
OR odds ratio
PD-1 programmed death receptor 1
TSH thyroid-stimulating hormone
VEGF vascular endothelial growth factor